Jennifer Ross
Profiles

Jennifer Ross, PhD

Associate Professor, Health Law, Policy & Management - Boston University School of Public Health

(999) 999-9999
Talbot (T Bldg)
View Full Profile at BUMC

Biography

Jennifer Cornacchione Ross, PhD, is an Associate Professor in the Department of Health Law, Policy, and Management at Boston University School of Public Health. She is a communication scientist who uses persuasion and health communication theories and methods to develop and test effective messages to reduce tobacco use and understand message features that may influence beliefs, such as tobacco industry marketing. Much of her work is focused on tobacco policy and regulation among priority populations, including adolescents, young adults, and those identifying as Black or African American. Through her work, Dr. Ross seeks to reduce tobacco-related disparities and provide evidence for implementing equitable tobacco policies. She is PI/MPI for two R01 studies funded by the National Cancer Institute to optimize and test the effectiveness of warnings for cigarillos among young adults and adolescents. Dr. Ross earned her PhD in Communication from Michigan State University and completed a postdoctoral fellowship in tobacco regulatory science at Wake Forest University School of Medicine.

Education

  • Michigan State University, PhD Field of Study: Communications

Websites

Classes Taught

  • SPHPH844
  • SPHPH885

Publications

  • Published on 2/24/2025

    Jebai R, Sutfin EL, Cassidy RN, Zizzi AR, Reboussin BA, Cornacchione Ross J. Relative Efficacy of Cigarillo Warning Statements in Text and Pictorial Formats: An Experimental Study Among a Sample of US Young Adults. Nicotine Tob Res. 2025 Feb 24; 27(3):525-533. PMID: 39320986.

     Read At: PubMed
  • Published on 2/11/2025

    Motta M, Callaghan T, Padmanabhan M, Ross JC, Gargano LM, Bowman S, Yokum D. Identifying and mitigating the public health consequences of meta-ignorance about "Long COVID" risks. Public Health. 2025 Feb 11; 241:19-23. PMID: 39938278.

     Read At: PubMed
  • Published on 2/6/2025

    Jebai R, Hong T, Ranker LR, Wu J, Rohila A, Fetterman JL, Cornacchione Ross J. Social Media Engagement and Quit Intentions among Youth with Exclusive E-cigarette Use: The Moderating Role of Social Norms. Nicotine Tob Res. 2025 Feb 06. PMID: 39912206.

     Read At: PubMed
  • Published on 1/15/2025

    Soule EK, Cornacchione Ross J, Lazard AJ, Jang H, Suerken CK, Kimes CM, Zizzi AR, Wagoner KG, Reboussin BA, Sutfin EL. Digital Marketing Strategies Used to Promote Waterpipe Tobacco Among Retailers and Manufacturers. Subst Use Misuse. 2025; 60(5):640-647. PMID: 39815410.

     Read At: PubMed
  • Published on 12/12/2024

    Ganz O, Ross JC. A topical examination of Cigar Aficionado magazine content, 2023. Tob Prev Cessat. 2024; 10. PMID: 39669262.

     Read At: PubMed
  • Published on 12/10/2024

    Jarman KL, Kistler CE, Thrasher JF, Kowitt SD, Ranney LM, Cornacchione Ross J, Chrzan K, Sheeran P, Goldstein AO. Identifying attributes of effective cigar warnings: a choice-based conjoint experiment in an online survey of US adults who smoke cigars. BMJ Open. 2024 Dec 10; 14(12):e088525. PMID: 39658281.

     Read At: PubMed
  • Published on 11/29/2024

    Wu J, Ranker LR, Origgi JM, Ma J, Hao D, Benjamin EJ, Cornacchione Ross J, Xuan Z, Wijaya D, Fetterman JL, Hong T. Protecting historically marginalized groups or targeted marketing? A computational analysis of individuals engaging with public and protected cigar-branded tweets. Drug Alcohol Depend. 2025 Jan 01; 266:112516. PMID: 39689499.

     Read At: PubMed
  • Published on 11/28/2024

    Sharma A, Belton A, Ozga JE, Ling P, Hrywna M, Cornacchione Ross J, Ganz O, Bold KW, Stanton C. Marketing strategies in business-to-business advertisements for oral nicotine products. Tob Control. 2024 Nov 28. PMID: 39613332.

     Read At: PubMed
  • Published on 11/19/2024

    Motta M, Callaghan T, Padmanabhan M, Ross J, Gargano LM, Bowman S, Yokum D. Quantifying the prevalence and determinants of respiratory syncytial virus (RSV) vaccine hesitancy in US adults aged 60 or older. Public Health. 2025 Jan; 238:3-6. PMID: 39566218.

     Read At: PubMed
  • Published on 11/10/2024

    Rubenstein D, Denlinger-Apte RL, Cornacchione Ross J, Carroll DM, McClernon FJ. Older age is associated with greater misperception of the relative health risk of e-cigarettes and cigarettes among US adults who smoke. Tob Control. 2024 Nov 10; 33(e2):e266-e269. PMID: 37137702.

     Read At: PubMed

View 81 more publications:View Full Profile at BUMC

News & In the Media

View all profiles